David M Mott Epizyme, Inc. (EPZM) insider trading activity

EPZM Quotes by TradingView

David M Mott is Director of Epizyme, Inc.. Currently has a direct ownership of 0 shares of EPZM, which is worth approximately $0. The most recent transaction as insider was on Aug 12, 2022, when has been sold 8,994 shares (Common Stock, par value $0.0001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

DAVID M MOTT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2022
SELL
Sale (or disposition) back to the issuer
-
8,994 Reduced 100.0%
0 Common Stock, par valu...
Aug 12 2022
SELL
Disposition due to a tender of shares in a change of control transaction
-
215,494 Reduced 95.99%
8,994 Common Stock, par valu...
Jun 30 2022
BUY
Grant, award, or other acquisition
$23,749 $1.47 p/Share
16,156 Added 6.71%
224,488 Common Stock, par valu...
May 17 2022
BUY
Grant, award, or other acquisition
-
8,994 Added 4.14%
208,332 Common Stock, par valu...
Mar 31 2022
BUY
Grant, award, or other acquisition
$23,751 $1.15 p/Share
20,653 Added 9.39%
199,338 Common Stock, par valu...
Dec 31 2021
BUY
Grant, award, or other acquisition
$23,750 $2.5 p/Share
9,500 Added 5.05%
178,685 Common Stock, par valu...
Sep 30 2021
BUY
Grant, award, or other acquisition
$23,757 $5.12 p/Share
4,640 Added 2.67%
169,185 Common Stock, par valu...
Jun 30 2021
BUY
Grant, award, or other acquisition
$23,750 $8.31 p/Share
2,858 Added 1.71%
164,545 Common Stock, par valu...
Jun 11 2021
BUY
Grant, award, or other acquisition
-
8,060 Added 4.75%
161,687 Common Stock, par valu...
Mar 31 2021
BUY
Grant, award, or other acquisition
$23,752 $8.71 p/Share
2,727 Added 1.74%
153,627 Common Stock, par valu...
Mar 26 2021
BUY
Open market or private purchase
$272,095 $7.89 p/Share
34,486 Added 18.6%
150,900 Common Stock, par valu...
Mar 25 2021
BUY
Open market or private purchase
$225,283 $7.98 p/Share
28,231 Added 19.52%
116,414 Common Stock, par valu...
Dec 31 2020
BUY
Grant, award, or other acquisition
$23,436 $10.86 p/Share
2,158 Added 2.39%
88,183 Common Stock, par valu...
Sep 30 2020
BUY
Grant, award, or other acquisition
$23,442 $11.93 p/Share
1,965 Added 2.23%
86,025 Common Stock, par valu...

Also insider at

MRSN
Mersana Therapeutics, Inc. Healthcare
Director
ARDX
ARDELYX, INC. Healthcare
Director
NVAX
NOVAVAX INC Healthcare
IMRA
IMARA Inc. Healthcare
Director
ADAP
Adaptimmune Therapeutics PLC Healthcare
Director
DMM

David M Mott

Director
Big Sky, MT

Track Institutional and Insider Activities on EPZM

Follow Epizyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EPZM shares.

Notify only if

Insider Trading

Get notified when an Epizyme, Inc. insider buys or sells EPZM shares.

Notify only if

News

Receive news related to Epizyme, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EPZM